FDA launches PreCheck pilot to speed review of new U.S. drug manufacturing facilities
The FDA has selected seven companies, including Eli Lilly and Regeneron, for its new PreCheck pilot program aimed at accelerating regulatory review of new pharmaceutical manufacturing facilities in the U.S. This program allows the FDA to review facil...
